- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Total 2274 results
-
Cancer Institute and Hospital, Chinese Academy...RecruitingGastric Cancer | Diffuse Type CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | Small-cell Lung Cancer | Lung Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHepatocellular Carcinoma | Radiotherapy | Narrow MarginChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Colorectal CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRefractory Solid Tumors | Relapsed Solid TumorsChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingCancer | Catheter Complications | Thrombosis, VenousChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRecurrence | Surgery | Thyroid CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutatedChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCOVID-19 Vaccine | COVID-19 InfectionChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBreast Cancer | Radiotherapy Side EffectChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck Cancer | Radiation DermatitisChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRadiotherapy | Rectal Neoplasms MalignantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Nasopharyngeal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingColorectal Cancer Stage IV | Hand and Foot Skin ReactionChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingColorectal Neoplasms MalignantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSoft Tissue Sarcoma | Radiotherapy Side Effect | Retroperitoneal Sarcoma | Ultra-hypofractionated Radiotherapy | Stereotactic Ablative RadiotherapyChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer | Radiotherapy Side Effect | Oligometastatic Disease | Magnetic Resonance-linac | Stereotactic Ablative RT | Adaptive Radiotherapy | Localised DiseaseChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingCervical Cancer Stage IB1China
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAnlotinib | Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound ComplicationsChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Triple-Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBreast CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemoradiation | Chemotherapy Effect | Immunotherapy | Targeted Therapy | Esophagus Cancer | Esophagogastric Junction CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSmall Cell Lung CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRecurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruiting
-
Cancer Institute and Hospital, Chinese Academy...CompletedEsophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | NimotuzumabChina
-
Cancer Institute and Hospital, Chinese Academy...CompletedEsophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Cancer Institute and Hospital, Chinese Academy...Completed